• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子对蛋白质命运决定的调控:靶向分子伴侣机制

Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery.

作者信息

Wang Lei, Xu Xiaoli, Jiang Zhengyu, You Qidong

机构信息

State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.

Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

出版信息

Acta Pharm Sin B. 2020 Oct;10(10):1904-1925. doi: 10.1016/j.apsb.2020.01.018. Epub 2020 Feb 7.

DOI:10.1016/j.apsb.2020.01.018
PMID:33163343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7606112/
Abstract

Modulation of protein fate decision and protein homeostasis plays a significant role in altering the protein level, which acts as an orientation to develop drugs with new mechanisms. The molecular chaperones exert significant biological functions on modulation of protein fate decision and protein homeostasis under constantly changing environmental conditions through extensive protein-protein interactions (PPIs) with their client proteins. With the help of molecular chaperone machinery, the processes of protein folding, trafficking, quality control and degradation of client proteins could be arranged properly. The core members of molecular chaperones, including heat shock proteins (HSPs) family and their co-chaperones, are emerging as potential drug targets since they are involved in numerous disease conditions. Development of small molecule modulators targeting not only chaperones themselves but also the PPIs among chaperones, co-chaperones and clients is attracting more and more attention. These modulators are widely used as chemical tools to study chaperone networks as well as potential drug candidates for a broader set of diseases. Here, we reviewed the key checkpoints of molecular chaperone machinery HSPs as well as their co-chaperones to discuss the small molecules targeting on them for modulation of protein fate decision.

摘要

蛋白质命运决定和蛋白质稳态的调节在改变蛋白质水平方面起着重要作用,这为开发具有新机制的药物提供了方向。分子伴侣通过与它们的客户蛋白广泛的蛋白质-蛋白质相互作用(PPI),在不断变化的环境条件下对蛋白质命运决定和蛋白质稳态的调节发挥着重要的生物学功能。在分子伴侣机制的帮助下,客户蛋白的蛋白质折叠、运输、质量控制和降解过程能够得到妥善安排。分子伴侣的核心成员,包括热休克蛋白(HSP)家族及其共伴侣,正成为潜在的药物靶点,因为它们参与了众多疾病状态。开发不仅靶向伴侣蛋白本身,而且靶向伴侣蛋白、共伴侣和客户蛋白之间PPI的小分子调节剂正越来越受到关注。这些调节剂被广泛用作研究伴侣蛋白网络的化学工具以及针对更广泛疾病的潜在候选药物。在此,我们综述了分子伴侣机制HSP及其共伴侣的关键检查点,以讨论靶向它们的小分子对蛋白质命运决定的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/dd2f8da5d60a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/9f1243b405eb/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/ecbf871f4758/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/dd2f8da5d60a/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/9f1243b405eb/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/ecbf871f4758/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca4/7606112/dd2f8da5d60a/gr2.jpg

相似文献

1
Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery.小分子对蛋白质命运决定的调控:靶向分子伴侣机制
Acta Pharm Sin B. 2020 Oct;10(10):1904-1925. doi: 10.1016/j.apsb.2020.01.018. Epub 2020 Feb 7.
2
Inhibitors and chemical probes for molecular chaperone networks.分子伴侣网络的抑制剂和化学探针。
J Biol Chem. 2019 Feb 8;294(6):2151-2161. doi: 10.1074/jbc.TM118.002813. Epub 2018 Sep 13.
3
Protein-Protein Interactions in the Molecular Chaperone Network.蛋白质-蛋白质相互作用在分子伴侣网络中。
Acc Chem Res. 2018 Apr 17;51(4):940-949. doi: 10.1021/acs.accounts.8b00036. Epub 2018 Apr 3.
4
With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage.有你或没有你:共伴侣通过调节伴侣功能和蛋白质分拣来介导健康和疾病。
Cells. 2021 Nov 11;10(11):3121. doi: 10.3390/cells10113121.
5
Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.靶向 Hsp90-Cdc37 客户蛋白相互作用以破坏 Hsp90 伴侣机制。
J Hematol Oncol. 2018 Apr 27;11(1):59. doi: 10.1186/s13045-018-0602-8.
6
Using Single-Molecule Approaches to Understand the Molecular Mechanisms of Heat-Shock Protein Chaperone Function.采用单分子方法理解热休克蛋白伴侣功能的分子机制。
J Mol Biol. 2018 Oct 26;430(22):4525-4546. doi: 10.1016/j.jmb.2018.05.021. Epub 2018 May 19.
7
Microbial molecular chaperones.微生物分子伴侣
Adv Microb Physiol. 2001;44:93-140. doi: 10.1016/s0065-2911(01)44012-4.
8
Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics.热休克蛋白与分子伴侣:对发病机制、诊断及治疗的意义
Int J Clin Lab Res. 1995;25(2):59-70. doi: 10.1007/BF02592359.
9
Regulatory chaperone complexes in neurodegenerative diseases: a perspective on therapeutic intervention.神经退行性疾病中的调控伴侣复合物:治疗干预的视角。
Curr Alzheimer Res. 2014 Jan;11(1):59-68. doi: 10.2174/1567205010666131119233044.
10
Heat shock protein 90: its inhibition and function.热休克蛋白 90:抑制与功能。
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738). doi: 10.1098/rstb.2016.0527.

引用本文的文献

1
Genetic variants in HSP40 co-chaperones modulate ischemic heart disease risk.热休克蛋白40(HSP40)共伴侣蛋白中的基因变异可调节缺血性心脏病风险。
Mol Biol Rep. 2025 Sep 10;52(1):889. doi: 10.1007/s11033-025-11014-z.
2
Advances in the structures, mechanisms and targeting of molecular chaperones.分子伴侣的结构、机制及靶向作用研究进展
Signal Transduct Target Ther. 2025 Mar 12;10(1):84. doi: 10.1038/s41392-025-02166-2.
3
The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics.热休克蛋白与癌症发病机制之间的相互作用:一种癌症治疗的新策略。

本文引用的文献

1
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.热休克蛋白 90 抑制剂:成就、挑战和未来方向的更新。
J Med Chem. 2020 Mar 12;63(5):1798-1822. doi: 10.1021/acs.jmedchem.9b00940. Epub 2019 Nov 12.
2
Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer.靶向结直肠癌中 HSP90-Cdc37 蛋白-蛋白相互作用的小分子抑制剂。
Sci Adv. 2019 Sep 18;5(9):eaax2277. doi: 10.1126/sciadv.aax2277. eCollection 2019 Sep.
3
Designing de Novo Small Molecules That Control Heat Shock Protein 70 (Hsp70) and Heat Shock Organizing Protein (HOP) within the Chaperone Protein-Folding Machinery.
Cancers (Basel). 2024 Feb 1;16(3):638. doi: 10.3390/cancers16030638.
4
Inhibition of Hsp110-STAT3 interaction in endothelial cells alleviates vascular remodeling in hypoxic pulmonary arterial Hypertension model.抑制内皮细胞中的 Hsp110-STAT3 相互作用可减轻低氧性肺动脉高压模型中的血管重构。
Respir Res. 2023 Nov 17;24(1):289. doi: 10.1186/s12931-023-02600-5.
5
Small molecules targeting protein-protein interactions for cancer therapy.靶向蛋白质-蛋白质相互作用的小分子用于癌症治疗。
Acta Pharm Sin B. 2023 Oct;13(10):4060-4088. doi: 10.1016/j.apsb.2023.05.035. Epub 2023 Jun 1.
6
Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation.发现有效的热休克蛋白 90(Hsp90)抑制剂:基于结构的虚拟筛选、分子动力学模拟和生物学评价。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2220558. doi: 10.1080/14756366.2023.2220558.
7
Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice.热休克蛋白 90(HSP90)抑制剂 Ganetespib 在癌症治疗中的作用:从分子机制到临床实践。
Int J Mol Sci. 2023 Mar 6;24(5):5014. doi: 10.3390/ijms24055014.
8
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches.白血病和淋巴瘤中的热休克蛋白:创新治疗方法的多靶点
Cancers (Basel). 2023 Feb 3;15(3):984. doi: 10.3390/cancers15030984.
9
Transcription Factors as Novel Therapeutic Targets and Drivers of Prostate Cancer Progression.转录因子作为前列腺癌进展的新型治疗靶点和驱动因素
Front Oncol. 2022 Apr 25;12:854151. doi: 10.3389/fonc.2022.854151. eCollection 2022.
10
Effect of Betaine and Arginine on Interaction of αB-Crystallin with Glycogen Phosphorylase .甜菜碱和精氨酸对 αB-晶体蛋白与糖原磷酸化酶相互作用的影响。
Int J Mol Sci. 2022 Mar 30;23(7):3816. doi: 10.3390/ijms23073816.
设计从头小分子,控制伴侣蛋白折叠机制内的热休克蛋白 70(Hsp70)和热休克组织蛋白(HOP)。
J Med Chem. 2019 Jan 24;62(2):742-761. doi: 10.1021/acs.jmedchem.8b01436. Epub 2018 Dec 20.
4
Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis.发现一种强效 Grp94 选择性抑制剂,在溃疡性结肠炎小鼠模型中具有抗炎疗效。
J Med Chem. 2018 Nov 8;61(21):9513-9533. doi: 10.1021/acs.jmedchem.8b00800. Epub 2018 Oct 26.
5
HSF1 as a Cancer Biomarker and Therapeutic Target.HSF1 作为癌症生物标志物和治疗靶点。
Curr Cancer Drug Targets. 2019;19(7):515-524. doi: 10.2174/1568009618666181018162117.
6
Inhibitors and chemical probes for molecular chaperone networks.分子伴侣网络的抑制剂和化学探针。
J Biol Chem. 2019 Feb 8;294(6):2151-2161. doi: 10.1074/jbc.TM118.002813. Epub 2018 Sep 13.
7
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice.KHS101 可破坏人胶质母细胞瘤细胞的能量代谢,并减少小鼠肿瘤生长。
Sci Transl Med. 2018 Aug 15;10(454). doi: 10.1126/scitranslmed.aar2718.
8
Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy.金纳米棒与热休克蛋白抑制剂VER-155008胶束联合用于结肠癌温和温度光热治疗。
Acta Pharm Sin B. 2018 Jul;8(4):587-601. doi: 10.1016/j.apsb.2018.05.011. Epub 2018 Jun 5.
9
DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction.DCZ3112,一种新型的 HSP90 抑制剂,通过破坏 HSP90-Cdc37 相互作用,对 HER2 阳性乳腺癌发挥强大的抗肿瘤活性。
Cancer Lett. 2018 Oct 10;434:70-80. doi: 10.1016/j.canlet.2018.07.012. Epub 2018 Jul 11.
10
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.具有阳离子成分的新型TRAP1和Hsp90伴侣蛋白抑制剂:线粒体靶向性的初步研究
Bioorg Med Chem Lett. 2018 Jul 15;28(13):2289-2293. doi: 10.1016/j.bmcl.2018.05.031. Epub 2018 May 15.